ABRI is an independent and neutral source of bio-products, offering a wide range of highly characterized biological samples for clinical trial management solutions and its own inventory of bio-products. With certifications from prestigious organizations such as NIH, CDC, and FDA, ABRI is known for its exceptional quality and regulatory compliance. Operating globally with locations in Miami, Santo Domingo, Guayaquil, Ahmedabad, and Costa de Marfil, ABRI is dedicated to providing timely and efficient delivery of high-quality samples to its customers.
ABRI's expertise lies in its understanding of the regulatory environment and project management capacities, enabling the commercialization of regulated products. Customers rely on ABRI to expedite their time to market, and the company operates with a worldwide permit from the CDC, FDA registration, and an Internal Review Board (IRB) to meet all standards and procedures. Additionally, ABRI actively seeks study participants to contribute to important medical innovations through clinical research, offering a state-of-the-art phase 1 facility and outpatient clinic for phases II-IV studies.
Generated from the website